Barei, F., Le Pen, C., & Simoens, S. (2012). From generic to biosimilar drugs: why take an innovative pace?. Farmeconomia. Health Economics and Therapeutic Pathways, 13(3S), 21–27. https://doi.org/10.7175/fe.v13i3S.328